01022-6/asset/a38873d9-5999-4e60-a3fc-c2fd1cbeca3d/main.assets/gr2_lrg.jpg)
cagrisema phase 3 results 2025 obesity cagrilintide semaglutide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Novo Nordisk's experimental obesity drug
Description
Based on proven semaglutide and cagrilintide components
Research has shown positive results, with participants who had obesity and prediabetes losing 12% to 19% of their body weight, depending on dosage
After doing my own research, I decided to try it alongside my physio exercises
The general math works as follows: Example A: 5,000 mcg vial + 2 mL bacteriostatic water: Yields 2,500 mcg per mL
Swirl gently never shake, which fractures peptide chains
[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Galarraga M, Campion J, Munoz-Barrutia A, Boque N, Moreno H, Martinez JA, Milagro F, Ortiz-de-Solorzano C
